Back to Merck Board
0
Discussion

Project Portfolio Review - Seeing a lot of projects shelved?

14
0x149a…8b27
·59d ago·1 comments
Lately, it feels like almost every other week a project I'm involved with or hear about is getting put on the back burner, or worse, completely shelved. It's not just one or two, it's across different departments and therapeutic areas. They're talking about 'strategic realignment' and 'prioritization,' but it feels like more than just a normal portfolio review. Budgets are being scrutinized intensely, and approvals for even minor expansions or new initiatives are taking forever, if they come at all. Anyone else seeing this pattern? It's making it hard to plan long-term, and honestly, the morale impact is starting to show. Feels like we're being asked to do more with less, and the 'why' isn't always clear. Just feels like a general tightening, but without any official word on what's actually happening. Curious to hear if others are experiencing this widespread project slowdown.

Join the discussion — anonymously

Sign in to comment, reply, and vote. Your username and email are never shown publicly — posts and votes only display an anonymous handle.

Sign in to post

Comments (1)

0
53
0x532e…653d
·59d ago

Yeah, I'm seeing the same thing. The 'strategic realignment' buzzwords are definitely being used a lot more, but it feels like a significant tightening across the board. It's tough when you're invested in certain projects and then see them put on hold indefinitely. Makes you wonder about the long-term vision or if there are some underlying financial pressures we're not fully aware of. The approval process is definitely a crawl these days, which adds to the frustration.